Literature DB >> 15302662

Young monozygotic twin sisters with fundus albipunctatus and cone dystrophy.

Makoto Nakamura1, Jian Lin, Yozo Miyake.   

Abstract

OBJECTIVE: To describe young monozygotic twin sisters with fundus albipunctatus (a type of autosomal recessive stationary night blindness caused by mutations of the 11-cis retinol dehydrogenase gene [RDH5]) associated with cone dystrophy, previously reported in elderly men.
METHODS: Ophthalmologic examinations were performed, and the RDH5 gene was analyzed by direct genomic sequencing.
RESULTS: Twin 23-year-old sisters with high myopic refractive errors of approximately -13 diopters were diagnosed as having fundus albipunctatus. Their photopic electroretinographic responses were markedly reduced, and cone dystrophy was diagnosed. One twin had macular degeneration with reduced best-corrected visual acuity, while the other twin had normal maculae with good visual acuity. A compound heterozygous mutation, Val132Met and Arg280His, in the RDH5 gene was found in both sisters.
CONCLUSIONS: Cone dystrophy can be present in patients with fundus albipunctatus, not only elderly men but also young women. The clinical severity differed between monozygotic twins with fundus albipunctatus and cone dystrophy.Clinical Relevance The patient's sex is not critical for the presence of cone dystrophy in patients with fundus albipunctatus. The discordant findings in the twins indicate that factors other than genetics influenced the phenotype.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15302662     DOI: 10.1001/archopht.122.8.1203

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  7 in total

Review 1.  Multimodal fundus imaging in fundus albipunctatus with RDH5 mutation: a newly identified compound heterozygous mutation and review of the literature.

Authors:  Nan-Kai Wang; Lan-Hsin Chuang; Chi-Chun Lai; Chai Lin Chou; Hsueh-Yen Chu; Ling Yeung; Yen-Po Chen; Kuan-Jen Chen; Wei-Chi Wu; Tun-Lu Chen; An-Ning Chao; Yih-Shiou Hwang
Journal:  Doc Ophthalmol       Date:  2012-06-06       Impact factor: 2.379

Review 2.  The retinal pigment epithelium in health and disease.

Authors:  J R Sparrow; D Hicks; C P Hamel
Journal:  Curr Mol Med       Date:  2010-12       Impact factor: 2.222

3.  A large animal model of RDH5-associated retinopathy recapitulates important features of the human phenotype.

Authors:  Laurence M Occelli; Anahita Daruwalla; Samantha R De Silva; Paige A Winkler; Kelian Sun; Nathaniel Pasmanter; Andrea Minella; Janice Querubin; Leslie A Lyons; Anthony G Robson; Elise Heon; Michel Michaelides; Andrew R Webster; Krzysztof Palczewski; Ajoy Vincent; Omar A Mahroo; Philip D Kiser; Simon M Petersen-Jones
Journal:  Hum Mol Genet       Date:  2022-04-22       Impact factor: 5.121

4.  Fundus albipunctatus: novel mutations and phenotypic description of Israeli patients.

Authors:  Eran Pras; Elon Pras; Haike Reznik-Wolf; Dror Sharon; Svetlana Raivech; Yaniv Barkana; Almogit Abu-Horowitz; Rotenstreich Ygal; Eyal Banin
Journal:  Mol Vis       Date:  2012-06-23       Impact factor: 2.367

5.  Novel mutations in RDH5 cause fundus albipunctatus in two consanguineous Pakistani families.

Authors:  Muhammad Ajmal; Muhammad Imran Khan; Kornelia Neveling; Yar Muhammad Khan; Syeda Hafiza Benish Ali; Waqas Ahmed; Muhammad Safdar Iqbal; Maleeha Azam; Anneke I den Hollander; Rob W J Collin; Raheel Qamar; Frans P M Cremers
Journal:  Mol Vis       Date:  2012-06-13       Impact factor: 2.367

6.  Novel variants in the RDH5 Gene in a Chinese Han family with fundus albipunctatus.

Authors:  Tianwei Qian; Qiaoyun Gong; Hangqi Shen; Caihua Li; Gao Wang; Xun Xu; Isabelle Schrauwen; Weijun Wang
Journal:  BMC Ophthalmol       Date:  2022-02-11       Impact factor: 2.209

7.  Postnatal onset of retinal degeneration by loss of embryonic Ezh2 repression of Six1.

Authors:  Naihong Yan; Lin Cheng; Kinsang Cho; Muhammad Taimur A Malik; Lirong Xiao; Chenying Guo; Honghua Yu; Ruilin Zhu; Rajesh C Rao; Dong Feng Chen
Journal:  Sci Rep       Date:  2016-09-28       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.